AI News NQ Analysis

Craif's urine cancer test 'mySignal Scan' certified as Kanagawa Prefecture's 'ME-BYO BRAND'

NQ Score 56/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the name of Craif's urine cancer test that received the 'ME-BYO BRAND' certification?
A: The name of Craif's urine cancer test that received the 'ME-BYO BRAND' certification is 'mySignal Scan'.
Q: What kind of technology does Craif use for its urine cancer test?
A: Craif uses its proprietary bio-AI technology, which analyzes microRNA in urine, for its urine cancer test.
Q: How many types of cancer risk can 'mySignal Scan' assess?
A: 'mySignal Scan' can assess the risk of 10 types of cancer, including pancreatic cancer, starting from stage 1.
Q: What is the 'ME-BYO BRAND' certification system established by Kanagawa Prefecture?
A: The 'ME-BYO BRAND' is a certification system established by Kanagawa Prefecture to certify excellent products and services that contribute to the visualization and improvement of 'Me-byo,' the state between health and illness.
Q: What is the primary benefit of using 'mySignal Scan' for cancer detection?
A: The primary benefit of using 'mySignal Scan' is its ability to provide highly accurate and convenient assessment of 10 types of cancer risk starting from stage 1, using a non-invasive urine sample.